MiR-744-5p/miR-615-3p and miR-324-3p have been reported to reverse cisplatin resistance and inhibit tumorigenesis in NSCLC by prompting GPX4-mediated ferroptosis [56,57]. The gene discussed is GPX4; the disease is non-small cell lung carcinoma.